🔗 Share this article

Treasury head Reeves has revealed she is planning "targeted steps to tackle cost of living pressures" in the upcoming Budget.

Speaking to media outlets, she stated that reducing price rises is a shared responsibility of both the government and the Bank of England.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven industrialized countries this calendar year and the following year.

Possible Utility Bill Measures

It is understood the administration could take action to bring down energy bills, for instance by reducing the present 5% level of VAT charged on energy supplies.

A further approach is to reduce some of the government charges presently added to household expenses.

Budgetary Constraints and Expert Predictions

The government will obtain the next draft from the official forecaster, the OBR, on Monday, which will show how much space there is for such actions.

The expectation from the majority of analysts is that the Chancellor will have to introduce tax rises or spending cuts in order to fulfill her declared debt limits.

Earlier on the same day, calculations indicated there was a twenty-two billion pound shortfall for the chancellor to address, which is at the more modest range of projections.

"There's a collective responsibility between the central bank and the government to continue tackling some of the drivers of price increases," Reeves stated to the BBC in Washington, at the conferences of the IMF and World Bank.

Tax Pledges and International Concerns

While a great deal of the focus has been on probable tax increases, the Treasury chief said the latest information from the fiscal watchdog had not altered her pledge to manifesto promises not to increase tax levels on earnings tax, VAT or social security contributions.

She blamed an "unpredictable world" with growing international and trade tensions for the fiscal tax moves, probably to be targeted on those "most able to pay."

Global Economic Disputes

Addressing concerns about the UK's trade ties with China she said: "The UK's security interests invariably take priority."

Recent statement by China to strengthen trade restrictions on critical minerals and other resources that are essential for advanced tech production led US President the US President to suggest an extra 100% tariff on imports from China, raising the risk of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary labeled China's move "economic coercion" and "a global supply chain power grab."

Asked about considering the American proposal to participate in its battle with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and called on the Chinese government "to avoid restrictions and limit trade."

She said the decision was "harmful for the international commerce and generates further challenges."

"In my view there are fields where we should address Chinese policies, but there are also significant prospects to export to China's economy, including financial services and other areas of the economy. We've got to get that equilibrium appropriate."

The chancellor also affirmed she was working with international partners "regarding our own essential resources plan, so that we are more independent."

Health Service Drug Pricing and Funding

Reeves also recognized that the price the NHS spends on medicines could increase as a consequence of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either pausing or abandoning investments in the UK, with several attributing the modest returns they are receiving.

Recently, the government science advisor said the cost the health service spends on medicines would need to increase to prevent firms and pharmaceutical investment departing from the United Kingdom.

Reeves informed the BBC: "It has been observed because of the pricing regime, that clinical trials, recent pharmaceuticals have not been available in the United Kingdom in the extent that they are in other continental states."

"We want to guarantee that individuals receiving care from the NHS are able to access the top critical medicines in the world. And so we are looking at these issues, and... looking to secure increased funding into the UK."